TEK and colorectal carcinoma: 1,4-dihydroxy quininib significantly decreased the expression of tyrosine-protein kinase receptor TIE-2 (TIE-2), and vascular cell adhesion protein (VCAM-1) in tumor conditioned media made from resected patient CRC tissue, and was well tolerated in mice [23].